Kazia Therapeutics Limited's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kazia Therapeutics Limited's ROI in the fourth quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Kazia Therapeutics Limited's return on investment (ROI) in its fourth quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) IV. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-8	-5	-5	-8	-3
Return On Investment (TTM)	-	-	-	-	-
KZIA's Overall Ranking	# 4169	# 4365	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-21	-27	-27	-27	-27

KZIA Company Profile >> Back to KZIA Roi Comparisons >> See Annual KZIA Return On Investment

Return On Investment KZIA's Ranking
Within:	No.
Industry	# 409
Sector	# 842
Overall	# 4169

Return On Investment Statistics
High	Average	Low
-16.92 %	-938.31 %	-6699.68 %
(Jun 30 2021)		(Jun 30 2025)

Financial Statements
Kazia Therapeutics Limited's IV. Quarter Investments	$ -8 Millions	KZIA's Balance sheet
Kazia Therapeutics Limited's IV. Quarter Income	$ -21 Millions	Quarterly KZIA's Income Statement
KZIA's Income by Division		See KZIA's Income by Division

KZIA Annual Return On Investment	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022	(Jun 30 2021) 2021
Total Investments in Millions	-5	-2	16	23	37
Y / Y Investment Growth	-	-	-32.94 %	-37.1 %	200.7 %
Net Income in Millions	-13	-18	-14	-18	-6
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-87.56 %	-77.37 %	-16.87 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KZIA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KZIA's Competitors
Subscribers only: Roi for Kazia Therapeutics Limited's Suppliers
Subscribers only: Return On Investment for KZIA's Customers

Other Ratios
KZIA's Roa	KZIA's Inventory Turnover Ratio	KZIA's Growth Rates	KZIA's Dividend Statistics
	KZIA's Profitability Ratios	KZIA's Asset Turnover Ratio	KZIA's Dividend Growth
KZIA's Roe	KZIA's Valuation Ratios	KZIA's Financial Strength Ratios	KZIA's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector	ROI
Glucotrack Inc	683.82 %
Pavmed Inc	417.70 %
Silexion Therapeutics Corp	376.46 %
Capforce Inc	177.96 %
Emmis Acquisition Corp	140.55 %
Oak Woods Acquisition Corp	106.75 %
Coherus Oncology inc	105.87 %
Interpace Biosciences Inc	102.53 %
Rigel Pharmaceuticals Inc	92.61 %
Cytomx Therapeutics Inc	80.43 %
Seres Therapeutics Inc	75.04 %
Gridai Technologies Corp	75.01 %
Earth Science Tech Inc	74.07 %
Stablecoin Development Corporation	66.04 %

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.